Rowan is a life sciences reporter for Chemical & Engineering News, reporting on the business of drug making. Rowan is particularly interested in exploring patient-centric drug development, with an eye toward clinical trial design, diversity, and how business leaders can help patients overcome barriers to health-care access.
Rowan previously spent 3 years as the life sciences reporter for the Boston Business Journal, taking the local angle in her coverage of the biotechnology, pharmaceutical, and medical device industries. Over the years, Rowan has reported for Mother Jones, the Boston Globe, and Boston magazine, among other publications, and has fact-checked for Wired, Eater, HuffPost, and others. Interests outside work include exploring the local arts scene, enjoying live music, hiking (when she's not overcoming her latest injury), and fostering cats. Rowan is originally from the Houston area and has a degree in journalism from Northeastern University.
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Already have an ACS ID? Log in here
ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.
$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students
ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.
Your account has been created successfully, and a confirmation email is on the way.
Your username is now your ACS ID.